Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Celltrion Inc

+ Add to Watchlist

068270:KS

74,700 KRW 2,800 3.61%

As of 21:31:00 ET on 05/25/2015.

Snapshot for Celltrion Inc (068270)

Open: 76,600 Day's Range: 74,300 - 77,000 Volume: 763,825
Previous Close: 77,500 52wk Range: 35,476 - 97,400 1-Yr Rtn: +60.84%

Stock Chart for 068270

No chart data available.
  • 068270:KS 74,500
  • 1D
  • 1M
  • 1Y
77,500
Interactive 068270 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 068270

Current P/E Ratio (ttm) 89.2473
Estimated P/E(12/2015) 84.7900
Relative P/E vs. KOSPI 4.7021
Earnings Per Share (KRW) (ttm) 837.0000
Est. EPS (KRW) (12/2015) 881.0000
Est. PEG Ratio -
Market Cap (M KRW) 8,288,679.06
Shares Outstanding (M) 110.96
30 Day Average Volume 2,549,115
Price/Book (mrq) 6.4819
Price/Sale (ttm) 15.8417
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 068270

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 068270

Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment.

Seo Jung-JinChairman/CEO/Rep DirectorPark Seong-DoVice Chairman
Hong Seung-SeoPresidentKim Gwang-HoPresident
More Company Profile & Key Executives for 068270

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil